Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18169
Country/Region: Eswatini
Year: 2018
Main Partner: Population Services International
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $3,638,471 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,030,557
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $1,492,516
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $1,115,398
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_SELF 10-14, Female, Directly-Assisted 2019 121
HTS_SELF 10-14, Female, Unassisted 2019 239
HTS_SELF 10-14, Male, Directly-Assisted 2019 121
HTS_SELF 10-14, Male, Unassisted 2019 121
HTS_SELF 15-19, Female, Directly-Assisted 2019 121
HTS_SELF 15-19, Female, Unassisted 2019 121
HTS_SELF 15-19, Male, Directly-Assisted 2019 361
HTS_SELF 15-19, Male, Unassisted 2019 601
HTS_SELF 20-24, Female, Directly-Assisted 2019 361
HTS_SELF 20-24, Female, Unassisted 2019 601
HTS_SELF 20-24, Male, Directly-Assisted 2019 361
HTS_SELF 20-24, Male, Unassisted 2019 601
HTS_SELF 25-29, Female, Directly-Assisted 2019 361
HTS_SELF 25-29, Female, Unassisted 2019 601
HTS_SELF 25-29, Male, Directly-Assisted 2019 361
HTS_SELF 25-29, Male, Unassisted 2019 601
HTS_SELF 30-34, Female, Directly-Assisted 2019 361
HTS_SELF 30-34, Female, Unassisted 2019 601
HTS_SELF 30-34, Male, Directly-Assisted 2019 361
HTS_SELF 30-34, Male, Unassisted 2019 601
HTS_SELF 35-39, Female, Directly-Assisted 2019 361
HTS_SELF 35-39, Female, Unassisted 2019 601
HTS_SELF 35-39, Male, Directly-Assisted 2019 361
HTS_SELF 35-39, Male, Unassisted 2019 601
HTS_SELF 40-49, Female, Directly-Assisted 2019 361
HTS_SELF 40-49, Female, Unassisted 2019 601
HTS_SELF 40-49, Male, Directly-Assisted 2019 361
HTS_SELF 40-49, Male, Unassisted 2019 1,175
HTS_SELF Unassisted - Other 2019 2,529
HTS_SELF Unassisted - Self 2019 2,529
HTS_SELF Unassisted - Sex Partner 2019 2,609
HTS_TST 25-29, Female, Negative 2019 576
HTS_TST 25-29, Female, Negative 2019 777
HTS_TST 25-29, Female, Negative 2019 394
HTS_TST 25-29, Male, Negative 2019 702
HTS_TST 25-29, Male, Negative 2019 951
HTS_TST 25-29, Male, Negative 2019 483
HTS_TST 30-34, Female, Negative 2019 384
HTS_TST 30-34, Female, Negative 2019 516
HTS_TST 30-34, Female, Negative 2019 263
HTS_TST 30-34, Male, Negative 2019 702
HTS_TST 30-34, Male, Negative 2019 951
HTS_TST 30-34, Male, Negative 2019 483
HTS_TST 35-39, Female, Negative 2019 321
HTS_TST 35-39, Female, Negative 2019 432
HTS_TST 35-39, Female, Negative 2019 220
HTS_TST 35-39, Male, Negative 2019 643
HTS_TST 35-39, Male, Negative 2019 864
HTS_TST 35-39, Male, Negative 2019 437
HTS_TST 40-49, Female, Negative 2019 321
HTS_TST 40-49, Female, Negative 2019 432
HTS_TST 40-49, Female, Negative 2019 220
HTS_TST 40-49, Male, Negative 2019 702
HTS_TST 40-49, Male, Negative 2019 951
HTS_TST 40-49, Male, Negative 2019 483
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 26,261
HTS_TST Service Delivery Point (Community) Index Mod: <1, Negative 2019 18
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2019 1,012
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2019 405
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2019 406
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 430
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 259
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 949
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 604
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 516
HTS_TST Service Delivery Point (Community) Mobile Testing: <1, Negative 2019 15
HTS_TST Service Delivery Point (Community) Mobile Testing: 1-9, Negative 2019 837
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Female, Negative 2019 336
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Male, Negative 2019 336
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 320
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 192
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 704
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 448
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 385
HTS_TST Service Delivery Point (Community) VCT Mod: <1, Negative 2019 7
HTS_TST Service Delivery Point (Community) VCT Mod: 1-9, Negative 2019 419
HTS_TST Service Delivery Point (Community) VCT Mod: 10-14, Female, Negative 2019 172
HTS_TST Service Delivery Point (Community) VCT Mod: 10-14, Male, Negative 2019 167
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Female, Negative 2019 220
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Male, Negative 2019 132
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Female, Negative 2019 481
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Male, Negative 2019 306
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Male, Negative 2019 263
HTS_TST_POS 25-29, Female, Positive 2019 45
HTS_TST_POS 25-29, Female, Positive 2019 127
HTS_TST_POS 25-29, Female, Positive 2019 65
HTS_TST_POS 25-29, Male, Positive 2019 54
HTS_TST_POS 25-29, Male, Positive 2019 160
HTS_TST_POS 25-29, Male, Positive 2019 79
HTS_TST_POS 30-34, Female, Positive 2019 28
HTS_TST_POS 30-34, Female, Positive 2019 85
HTS_TST_POS 30-34, Female, Positive 2019 43
HTS_TST_POS 30-34, Male, Positive 2019 54
HTS_TST_POS 30-34, Male, Positive 2019 160
HTS_TST_POS 30-34, Male, Positive 2019 79
HTS_TST_POS 35-39, Female, Positive 2019 25
HTS_TST_POS 35-39, Female, Positive 2019 72
HTS_TST_POS 35-39, Female, Positive 2019 35
HTS_TST_POS 35-39, Male, Positive 2019 51
HTS_TST_POS 35-39, Male, Positive 2019 141
HTS_TST_POS 35-39, Male, Positive 2019 72
HTS_TST_POS 40-49, Female, Positive 2019 25
HTS_TST_POS 40-49, Female, Positive 2019 72
HTS_TST_POS 40-49, Female, Positive 2019 35
HTS_TST_POS 40-49, Male, Positive 2019 54
HTS_TST_POS 40-49, Male, Positive 2019 160
HTS_TST_POS 40-49, Male, Positive 2019 79
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2019 40
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Female, Positive 2019 16
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Male, Positive 2019 18
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 72
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2019 43
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 158
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 98
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2019 85
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 25
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 16
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 54
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 34
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2019 28
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 15-19, Female, Positive 2019 34
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 15-19, Male, Positive 2019 20
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 20-24, Female, Positive 2019 79
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 20-24, Male, Positive 2019 51
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 50+, Male, Positive 2019 43
TX_CURR 25-29, Female, Positive 2019 133
TX_CURR 25-29, Male, Positive 2019 83
TX_CURR 30-34, Female, Positive 2019 133
TX_CURR 30-34, Male, Positive 2019 83
TX_CURR 35-39, Female, Positive 2019 182
TX_CURR 35-39, Male, Positive 2019 133
TX_CURR 40-49, Female, Positive 2019 282
TX_CURR 40-49, Male, Positive 2019 166
TX_CURR Age/Sex: <1 2019 3
TX_CURR Age/Sex: <1-9 2019 52
TX_CURR Age/Sex: 10-14 Female 2019 25
TX_CURR Age/Sex: 10-14 Male 2019 25
TX_CURR Age/Sex: 15-19 Female 2019 33
TX_CURR Age/Sex: 15-19 Male 2019 17
TX_CURR Age/Sex: 20-24 Female 2019 83
TX_CURR Age/Sex: 20-24 Male 2019 17
TX_CURR Age/Sex: 50+ Female 2019 182
TX_CURR Age/Sex: 50+ Male 2019 133
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 1,763
TX_CURR Sum of age/sex disaggregates 2019 50
TX_NEW 25-29, Female, Positive 2019 28
TX_NEW 25-29, Male, Positive 2019 35
TX_NEW 30-34, Female, Positive 2019 21
TX_NEW 30-34, Male, Positive 2019 42
TX_NEW 35-39, Female, Positive 2019 28
TX_NEW 35-39, Male, Positive 2019 45
TX_NEW 40-49, Female, Positive 2019 24
TX_NEW 40-49, Male, Positive 2019 45
TX_NEW Breastfeeding status 2019 175
TX_NEW By Age/Sex: <1 2019 1
TX_NEW By Age/Sex: 1-9 2019 5
TX_NEW By Age/Sex: 10-14 Female 2019 3
TX_NEW By Age/Sex: 10-14 Male 2019 3
TX_NEW By Age/Sex: 15-19 Female 2019 10
TX_NEW By Age/Sex: 15-19 Male 2019 7
TX_NEW By Age/Sex: 20-24 Female 2019 24
TX_NEW By Age/Sex: 20-24 Male 2019 10
TX_NEW By Age/Sex: 50+ Female 2019 7
TX_NEW By Age/Sex: 50+ Male 2019 21
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 360
TX_NEW Pregnancy status 2019 175
TX_NEW Sum of Age/Sex disaggregates 2019 85
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 1,743
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 52
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 52
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 976
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 662
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 190
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 190
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 380
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 404
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 202
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 202